At the Core of the Latest Pharm-to-Table Dispute: Which GLP-1 Was Hims Preferring?
Shares:
There’s a lot to go through this morning. Let’s get at it. I’m thinking about rare diseases this morning for a couple of reasons. First, there is this JAMA Internal
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
So I managed to screw up at least two things yesterday. First off, I misspelled Leana Wen’s name. Second, I included the wrong link in discussing Wen’s op-ed. The right